About Conference
ESMO 2025 will be a place where groundbreaking discoveries, cutting-edge treatments and collaborative approach converge to shape the future of cancer care.
Highlights
The ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Certain surgical gestures during prostate removal linked to better sexual function recovery
2.
AI tool accurately detects tumor location on breast MRI
3.
Prostate cancer early detection system eliminates need for biopsy.
4.
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC
5.
Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC
1.
Decoding the Future: Cancer Genomics and Radiomics in Oncology
2.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
3.
Precision to Personalization: Expanding Genetic Testing and Counseling in Oncology
4.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
5.
A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
5.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
Recommended News For You
1.
healthy despite having advanced cancer.
2.
Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer
3.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
4.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
5.
Treating advanced prostate cancer
Conferences That Might Interest You
Recommended Articles For You
1.
Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions
2.
Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential
3.
A Closer Look at MCV Modules: Features, Functions, and Benefits
4.
Unlocking the Potential of SABCS 2022: Innovative Strategies for Cancer Research
5.
Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial
Boost Your Knowledge With These Quizzes
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge